Navigation Links
Pro-Dex, Inc. Announces Fiscal 2013 Fourth Quarter And Full-Year Results
Date:9/25/2013

ast a shadow over our results since fiscal 2010.  We are happy to close this chapter, and look forward to focusing our comments on the revenue rebuilding effort, which we believe is the true measure of our revenue performance."

"As pleased as we are with a 17% year-over-year reduction in operating expenses, this comparison does not fully reflect our progress in right-sizing our expense footprint.  During fiscal 2013 we reduced the composition of our senior management team from six to four members, and our headcount from 74 to 67.  As a result, our annualized base compensation was reduced from $4.6 million at June 30, 2012 to $3.7 million at June 30, 2013, a 20% decrease.  In addition, we have renegotiated the rental rate for the remainder of the lease term for our facility in Irvine, California that will result in a reduction of annualized expense of approximately $51,000, and annualized compensation for non-employee members of our Board of Directors has been reduced by approximately $140,000 compared to recent years based on a new compensation plan approved by our Board in May 2013.  We enjoyed but a portion of the benefits of these, among many other, cost savings measures in fiscal 2013, and we are looking forward to realizing the full-year effect of our efforts in the current fiscal year 2014."

"During fiscal 2013, we invested $1.0 million in inventory growth, principally to accommodate delivery commitments to our largest customer based on its anticipated delivery requirements.  In the fiscal 2013 fourth quarter, we learned from this customer of its need to schedule deliveries for later dates than originally anticipated.  As a result, conversion to cash of the inventory related to this customer will likely be weighted toward the second half of the current fiscal year 2014 and possibly the first half of fiscal year 2015."

"Even with this unanticipated prolonged investment in inventory, we continue to maintain
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
3. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
6. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
7. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
8. Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
9. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
10. Pro-Dex, Inc. Appoints Harold A. Hurwitz Chief Executive Officer
11. Pro-Dex, Inc. Appoints Richard Van Kirk Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015 /CNW/ - Export Development Canada (EDC) today announced a ... Montreal,s Valeant Pharmaceuticals International, Inc. (Valeant), ... The loan is part of a ... is using to fund the repayment of certain outstanding ... pharmaceutical company based in the US. Salix was acquired ...
(Date:5/26/2015)... 26, 2015  Haemonetics Corporation (NYSE: HAE ) ... Investor Relations, will present at The East Coast IDEAS ... June 4 th , 2015 at 2:30pm Eastern time.  ... presentation live via webcast at: http://www.wsw.com/webcast/threepa16/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/26/2015)... May 26, 2015  Amgen (NASDAQ: AMGN ) ... Phase 3 OPTiM study in the Journal of ... data published in JCO , which were previously ... of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated ... with unresected stage IIIB, IIIC or IV metastatic melanoma ...
Breaking Medicine Technology:EDC provides Valeant Pharmaceuticals with USD 67.5 M to support recent Salix Pharmaceuticals acquisition 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8
... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... products for central nervous system disorders, today announced it will ... May 5, 2011, before the market opens. A full text ... Mihael H. Polymeropoulos, M.D., President and Chief Executive ...
... NEW BRAUNFELS, Texas, April 22, 2011 One hundred and ... challenge bike riders in the BP MS 150 overcame on ... Sclerosis. Team Freedom, a corporate team sponsored by The ... solutions and services, completed the two-day ride and raised nearly ...
Cached Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011 2The SCOOTER Store Supports Fight Against Multiple Sclerosis 2
(Date:5/27/2015)... One of America's most cherished actors, James Earl ... that takes a look at the topic of atrial ... abnormal heart rhythm. Those who suffer from atrial fibrillation ... too quickly. , This new segment will take a ... to inform viewers about possible signs that commonly indicate ...
(Date:5/27/2015)... 27, 2015 The Academy of Oncology ... Coast Regional Meeting in Seattle. This intimate gathering, held ... 200 navigation and oncology professionals from west of the ... , “One of the most important things that an ... their needs and do the best it can to ...
(Date:5/26/2015)... 27, 2015 Carey Danis & ... testosterone gel lawsuit . The suit pertains to AndroGel, ... was filed in late April 2015, and a court ... Illinois federal court in mid-May.¹ , Testosterone gel lawsuits ... the Northern District of Illinois. The multidistrict litigation (MDL) ...
(Date:5/26/2015)... Readers who struggle with memory , ... Chester Litvin ’s new book, “ Introduction to ... Trafford Publishing). , Litvin, who is a clinical psychologist, ... This book will guide readers through a series of ... cells . He shares his patented process for reviving ...
(Date:5/26/2015)... Liverpool, Ohio (PRWEB) May 26, 2015 Mr. ... role since 2010, will start working together this week to ... an accomplished career in healthcare executive leadership and strategy. ... CEO prior to the hiring of Mr. Cochran. The Board ... skills will complement the improvement strategies implemented over the past ...
Breaking Medicine News(10 mins):Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 2Health News:AONN+’s West Coast Regional Meeting Brings Oncology Nurse and Patient Navigators Together for Two Days of Education and Networking 3Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3
... Harvard Medical School, of more than 100,000 women, indicates ... either psychiatric// illnesses or other conditions, may have an ... about 52,000 women who were taking dopamine antagonists and ... compared for breast cancer rates. It was found that ...
... of Nature Medicine by researchers in Rene Descartes University has ... vaccine which may one day let people quit their AIDS ... promising results, and if confirmed and adapted in humans may ... researchers reported that the new vaccine uses a type of ...
... age people are now increasingly taking to gardening as a ... of beautiful gardens. Though gardening has been proven to have ... gardeners who start with little or no idea of how ... up having severe back pain. ,A recent study of ...
... published in the British Medical Journal suggests that there is ... of their offspring. In contrast to overweight children given birth ... are likely to weigh less than other children. ... 186 grams less than other children and this significant difference ...
... ancient Chinese medical practices that has gained widespread ... suggest that along with other therapies, the traditional ... paediatric patients. ,A recent study which shows ... to acupuncturists, proves the popularity of the traditional ...
... Dietary Supplements & Diabetes ,A recent ... conducted by Dr.Vijay Jayagopal and his colleagues from the ... understand the benefits of dietary supplements on type 2 ... menopausal women with type 2 diabetes who //either received ...
Cached Medicine News:Health News:A Compilation of recent Diabetes Research articles 2
... the best of both worlds, the ... is the latest addition to the ... bipolar cautery instruments for ophthalmic surgery. ... extrusion aspiration and backflush functionality in ...
...
...
...
Medicine Products: